---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033731"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:51:43.309004+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ensysce Biosciences receives Nasdaq delisting notice for equity shortfall

## Summary
- Notice received August 20, 2024; non-compliance with $2.5 million stockholders' equity minimum as of June 30, 2024.
- Company plans to timely request a hearing before the Nasdaq Hearings Panel, which will stay delisting action.
- No assurance that the Panel will grant continued listing or that compliance can be shown before any extension expires.

## SEC filing metadata
- accession: 0001493152-24-033731
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315224033731/0001493152-24-033731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315224033731/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033731
- JSON: https://secwatch.observer/filing/0001493152-24-033731.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033731.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.